4.6 Article

Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics

Journal

METABOLITES
Volume 11, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/metabo11040199

Keywords

bladder cancer; volatile biomarkers; diagnosis; staging; urine; gas chromatography-mass spectrometry

Funding

  1. Applied Molecular Biosciences Unit-UCIBIO - FCT [UIDB/04378/2020]
  2. FCT [SFRH/BD/123012/2016]
  3. project MindGAP - European Union (BM-1-GEBC-H2020-FETOPEN-2018-2020)
  4. Fundação para a Ciência e a Tecnologia [SFRH/BD/123012/2016] Funding Source: FCT

Ask authors/readers for more resources

Timely diagnosis is crucial for improving the long-term survival of bladder cancer patients. A study was conducted to analyze the urinary volatile profile of BC patients using urine samples, revealing distinct volatile signatures and potential biomarkers for non-invasive detection and staging. The results showed differences in urinary volatile profiles among patients diagnosed at different tumor stages, suggesting a promising approach for BC diagnosis and staging.
Timely diagnosis is crucial to improve the long-term survival of bladder cancer (BC) patients. The discovery of new BC biomarkers based in urine analysis is very attractive because this biofluid is in direct contact with the inner bladder layer, in which most of the neoplasms develop, and is non-invasively collected. Hence, this work aimed to unveil alterations in the urinary volatile profile of patients diagnosed with BC compared with cancer-free individuals, as well as differences among patients diagnosed at different tumor stages, to identify candidate biomarkers for non-invasive BC diagnosis and staging. Urine analysis was performed by headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry (HS-SPME-GC-MS). The results unveiled that BC patients have a distinct urinary volatile profile characterized by higher levels of several alkanes and aromatic compounds, and lower levels of aldehydes, ketones and monoterpenes. Seventeen significantly altered volatiles were used to evaluate the performance for overall BC detection, disclosing 70% sensitivity, 89% specificity and 80% accuracy. Moreover, distinct urinary volatile profiles were found among patients diagnosed at different tumor stages (Ta/Tis, T1 and >= T2). This work identified distinct urinary volatile signatures of BC patients with potential for non-invasive detection and staging of bladder cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available